Androgen deprivation therapy for prostate cancer: recommendations to improve patient and partner quality of life
- PMID: 20626600
- DOI: 10.1111/j.1743-6109.2010.01902.x
Androgen deprivation therapy for prostate cancer: recommendations to improve patient and partner quality of life
Abstract
Introduction: Because of improved prostate cancer detection, more patients begin androgen deprivation therapy (ADT) earlier and remain on it longer than before. Patients now may be androgen deprived for over a decade, even when they are otherwise free of cancer symptoms.
Aim: An ADT Survivorship Working Group was formed to develop and evaluate interventions to limit the physiological and emotional trauma patients and their partners experience from this treatment.
Methods: The multidisciplinary Working Group met for 2 days to define the challenges couples face when patients commence ADT. A writing sub-group was formed. It compiled the meeting's proceedings, reviewed the literature and, in consultation with the other members of the working group, wrote the manuscript.
Main outcome measures: Expert opinion of the side effects of ADT that affect the quality of life (QOL) of patients and their partners and the recommendations for managing ADT to optimize QOL were based on the best available literature, clinical experience, and widespread internal discussions among Working Group members.
Results: Side effects identified as particularly challenging include: (i) body feminization; (ii) changes in sexual performance; (iii) relationship changes; (iv) cognitive and affective symptoms; and (v) fatigue, sleep disturbance, and depression. Recommendations for managing ADT include providing information about ADT side effects before administration of ADT, and, where appropriate, providing referrals for psychosocial support. Sexual rehabilitation principles for persons with chronic illness may prove useful. Psychological interventions for sexual sequelae need to be offered and individualized to patients, regardless of their age or partnership. Support should also be offered to partners.
Conclusions: Our hope is that this plan will serve as a guide for optimizing how ADT is carried out and improve the lives of androgen-deprived men and their intimate partners.
© 2010 International Society for Sexual Medicine.
Similar articles
-
The unique needs of couples experiencing androgen deprivation therapy for prostate cancer.J Sex Marital Ther. 2010;36(2):154-65. doi: 10.1080/00926230903554552. J Sex Marital Ther. 2010. PMID: 20169495 Review.
-
Androgen deprivation therapy: evidence-based management of side effects.BJU Int. 2013 Apr;111(4):543-8. doi: 10.1111/j.1464-410X.2012.11774.x. Epub 2013 Jan 25. BJU Int. 2013. PMID: 23351025 Review.
-
Patients and partners lack knowledge of androgen deprivation therapy side effects.Urol Oncol. 2013 Oct;31(7):1098-105. doi: 10.1016/j.urolonc.2011.12.015. Epub 2012 Jan 30. Urol Oncol. 2013. PMID: 22285008
-
Maintaining intimacy for prostate cancer patients on androgen deprivation therapy.Curr Opin Support Palliat Care. 2016 Mar;10(1):55-65. doi: 10.1097/SPC.0000000000000190. Curr Opin Support Palliat Care. 2016. PMID: 26761788 Review.
-
Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners.Cancer. 2015 Dec 15;121(24):4286-99. doi: 10.1002/cncr.29672. Epub 2015 Sep 15. Cancer. 2015. PMID: 26372364 Review.
Cited by
-
A Non-Randomized Comparison of Online and In-Person Formats of the Canadian Androgen Deprivation Therapy Educational Program: Impacts on Side Effects, Bother, and Self-Efficacy.Curr Oncol. 2024 Aug 28;31(9):5040-5056. doi: 10.3390/curroncol31090373. Curr Oncol. 2024. PMID: 39330001 Free PMC article.
-
Impact of neoadjuvant relugolix on patient-reported sexual function and bother.Front Oncol. 2024 Apr 11;14:1377103. doi: 10.3389/fonc.2024.1377103. eCollection 2024. Front Oncol. 2024. PMID: 38665954 Free PMC article.
-
UPDATE - Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies.Can Urol Assoc J. 2022 Aug;16(8):E416-E431. doi: 10.5489/cuaj.8054. Can Urol Assoc J. 2022. PMID: 35905482 Free PMC article. No abstract available.
-
The relationship between sleep hygiene, mood, and insomnia symptoms in men with prostate cancer.Support Care Cancer. 2022 May;30(5):4055-4064. doi: 10.1007/s00520-021-06680-1. Epub 2022 Jan 22. Support Care Cancer. 2022. PMID: 35064327
-
The Psychosocial Consequences of Prostate Cancer Treatments on Body Image, Sexuality, and Relationships.Front Psychol. 2021 Oct 22;12:765315. doi: 10.3389/fpsyg.2021.765315. eCollection 2021. Front Psychol. 2021. PMID: 34744944 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous